To determine if increased phosphorylation of eIF2α in ABT-888 treated cancer cells contributes to the sensitizing effect of vorinostat, we evaluated the effect of salubrinal—an inhibitor of eIF2α dephosphorylation—on the sensitivity of the cells to ABT-888. Here, EIF2A is linked to cancer.